127 related articles for article (PubMed ID: 7423026)
1. Levorphanol:radioimmunoassay and plasma concentration profiles in dog and man.
Dixon R; Crews T; Mochacsi E; Inturrisi C; Foley K
Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):535-47. PubMed ID: 7423026
[TBL] [Abstract][Full Text] [Related]
2. Levorphanol: a simplified radioimmunoassay for clinical use.
Dixon R; Crews T; Mohacsi E; Inturrisi C; Foley K
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):545-8. PubMed ID: 7268198
[TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.
Dixon R; Carbone JJ; Mohacsi E; Perry C
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):243-55. PubMed ID: 734214
[TBL] [Abstract][Full Text] [Related]
4. Levorphanol: pharmacokinetics and steady-state plasma concentrations in patients with pain.
Dixon R; Crews T; Inturrisi C; Foley K
Res Commun Chem Pathol Pharmacol; 1983 Jul; 41(1):3-17. PubMed ID: 6194546
[TBL] [Abstract][Full Text] [Related]
5. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
6. Specific radioimmunoassay for amitriptyline and nortriptyline in plasma.
Lucek R; Dixon R
Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):125-36. PubMed ID: 905625
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay and plasma concentrations of the anti-allergenic agent, 2-methoxy-11-oxo-11-H-pyrido[2,1-b]quinazoline-8-carboxylic acid in man.
Dixon R; Lucek R; Liu YY; Colburn W; Parsonnet M
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):163-70. PubMed ID: 7433765
[TBL] [Abstract][Full Text] [Related]
8. Midazolam: radioimmunoassay for pharmacokinetic studies in man.
Dixon R; Lucek R; Todd D; Walser A
Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):11-20. PubMed ID: 7122996
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of atropine in plasma.
Wurzburger RJ; Miller RL; Boxenbaum HG; Spector S
J Pharmacol Exp Ther; 1977 Nov; 203(2):435-41. PubMed ID: 909073
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
Usui T; Watanabe T; Higuchi S
Drug Metab Dispos; 1995 Nov; 23(11):1214-9. PubMed ID: 8591721
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay and pharmacokinetic profile of bupropion in the dog.
Butz RF; Schroeder DH; Welch RM; Mehta NB; Phillips AP; Findlay JW
J Pharmacol Exp Ther; 1981 Jun; 217(3):602-10. PubMed ID: 6785419
[TBL] [Abstract][Full Text] [Related]
12. A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations.
Wurzburger RJ; Miller RL; Marcum EA; Colburn WA; Spector S
J Pharmacol Exp Ther; 1981 Jun; 217(3):757-63. PubMed ID: 7230004
[TBL] [Abstract][Full Text] [Related]
13. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
14. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
Monji N; Castro A
Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Methadone: radioimmunoassay and pharmacokinetics in the rat.
Ling GS; Umans JG; Inturrisi CE
J Pharmacol Exp Ther; 1981 Apr; 217(1):147-51. PubMed ID: 7205649
[TBL] [Abstract][Full Text] [Related]
17. Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat.
Anadón A; Martinez-Larrañaga MR; Fernandez-Cruz ML; Diaz MJ; Fernandez MC; Martinez MA
Toxicol Appl Pharmacol; 1996 Nov; 141(1):8-16. PubMed ID: 8917670
[TBL] [Abstract][Full Text] [Related]
18. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of buprenorphine following intravenous administration in dogs.
Krotscheck U; Boothe DM; Little AA
Am J Vet Res; 2008 Jun; 69(6):722-7. PubMed ID: 18518651
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
